Department of Immunology, Faculty of Medicine, Imperial College, London, United Kingdom.
PLoS Pathog. 2010 Sep 23;6(9):e1001117. doi: 10.1371/journal.ppat.1001117.
CD8(+) T cells can exert both protective and harmful effects on the virus-infected host. However, there is no systematic method to identify the attributes of a protective CD8(+) T cell response. Here, we combine theory and experiment to identify and quantify the contribution of all HLA class I alleles to host protection against infection with a given pathogen. In 432 HTLV-1-infected individuals we show that individuals with HLA class I alleles that strongly bind the HTLV-1 protein HBZ had a lower proviral load and were more likely to be asymptomatic. We also show that in general, across all HTLV-1 proteins, CD8(+) T cell effectiveness is strongly determined by protein specificity and produce a ranked list of the proteins targeted by the most effective CD8(+) T cell response through to the least effective CD8(+) T cell response. We conclude that CD8(+) T cells play an important role in the control of HTLV-1 and that CD8(+) cells specific to HBZ, not the immunodominant protein Tax, are the most effective. We suggest that HBZ plays a central role in HTLV-1 persistence. This approach is applicable to all pathogens, even where data are sparse, to identify simultaneously the HLA Class I alleles and the epitopes responsible for a protective CD8(+) T cell response.
CD8(+) T 细胞对病毒感染宿主既具有保护作用,也具有有害作用。然而,目前还没有系统的方法来确定保护性 CD8(+) T 细胞反应的属性。在这里,我们结合理论和实验,确定并量化了所有 HLA Ⅰ类等位基因对宿主抵御特定病原体感染的保护作用。在 432 名 HTLV-1 感染者中,我们发现与 HTLV-1 蛋白 HBZ 结合能力较强的 HLA Ⅰ类等位基因的个体,其前病毒载量较低,且更有可能无症状。我们还表明,一般来说,在所有 HTLV-1 蛋白中,CD8(+) T 细胞的有效性主要由蛋白特异性决定,并根据最有效的 CD8(+) T 细胞反应靶向的蛋白,对其进行从最有效到最无效的排序。我们的结论是,CD8(+) T 细胞在控制 HTLV-1 中发挥着重要作用,针对 HBZ 的 CD8(+)细胞而非免疫显性蛋白 Tax,是最有效的。我们认为 HBZ 在 HTLV-1 的持续存在中起着核心作用。这种方法适用于所有病原体,即使数据较少,也可以同时确定负责保护性 CD8(+) T 细胞反应的 HLA Ⅰ类等位基因和表位。